Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Skepinone-L (CBS3830) 是一种选择性 p38 丝裂原活化蛋白激酶抑制剂。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 282 | 现货 | ||
2 mg | ¥ 416 | 现货 | ||
5 mg | ¥ 747 | 现货 | ||
10 mg | ¥ 1,230 | 现货 | ||
25 mg | ¥ 1,980 | 现货 | ||
50 mg | ¥ 2,970 | 现货 | ||
100 mg | ¥ 4,350 | 现货 | ||
500 mg | ¥ 9,380 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 822 | 现货 |
产品描述 | Skepinone-L (CBS3830) is a selective p38 mitogen-activated protein kinase inhibitor. |
靶点活性 | p38α:5 nM |
体外活性 | Skepinone-L shows concentration-dependent inhibition of HSP27 (Ser82) phosphorylation through the p38 MAPK pathway with a cellular IC50 of approximately 25 nM, and also reduces concentrations of TNF-α, IL-1β and IL-10, regulated by p38 MAPK, with IC50 ranging from 30 to 50 nM . [1] Skepinone-L (1 μM) abrogates the phosphorylation of platelet p38 MAPK substrate Hsp27 activated by stimulation with CRP, thrombin or thromboxane A2 analogue U-46619, and impairs platelet secretion and aggregation. [2] |
体内活性 | In vivo, skepinone-L inhibits Gal/ LPS-induced TNF-α release by 77%. [1] |
激酶实验 | CDK1 kinase activity is tested by the CDK1/cyclin B complex purified from baculovirus to phosphorylate a biotinylated peptide substrate containing the consensus phosphorylation site for histone H1, which is phosphorylated in vivo by CDK1. Inhibition of CDK1 activity is measured by observing a decreased amount of 33P-γ-ATP incorporation into the immobilized substrate in streptavidin-coated 96-well scintillating microplates. CDK1 enzyme is diluted in 50 mM Tris-HCl (pH 8), 10 mM MgCl2, 0.1 mM Na3VO4, 1 mM DTT, 1% DMSO, 0.25 μM peptide, 0.1 μCi per well 33P-γ-ATP, and 5 μM ATP in the presence or absence of various concentrations of JNJ-7706621 and incubated at 30 °C for 1 hour. The reaction is terminated by washing with PBS containing 100 mM EDTA and plates are counted in a scintillation counter. IC50 is determined by Linear regression analysis of the percent inhibition by JNJ-7706621. |
细胞实验 | Concentrations: 1 nM - 10 μM, dissolved in DMSO |
别名 | CBS3830 |
分子量 | 425.42 |
分子式 | C24H21F2NO4 |
CAS No. | 1221485-83-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 79 mg/mL (185.7 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: 79 mg/mL (185.7 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO / Ethanol | 1 mM | 2.3506 mL | 11.7531 mL | 23.5062 mL | 58.7655 mL |
5 mM | 0.4701 mL | 2.3506 mL | 4.7012 mL | 11.7531 mL | |
10 mM | 0.2351 mL | 1.1753 mL | 2.3506 mL | 5.8765 mL | |
20 mM | 0.1175 mL | 0.5877 mL | 1.1753 mL | 2.9383 mL | |
50 mM | 0.047 mL | 0.2351 mL | 0.4701 mL | 1.1753 mL | |
100 mM | 0.0235 mL | 0.1175 mL | 0.2351 mL | 0.5877 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Skepinone-L 1221485-83-1 Autophagy MAPK p38 MAPK inhibit SkepinoneL Skepinone L CBS3830 CBS 3830 CBS-3830 Inhibitor inhibitor